Lipoprotein Distribution of a Novel Endotoxin Antagonist, E5531, in Plasma from Human Subjects with Various Lipid Levels

Eitemau Tebyg

• Consequences of Interaction of a Lipophilic Endotoxin Antagonist with Plasma Lipoproteins
  gan: Rose, Jeffrey R., et al.
  Cyhoeddwyd: (2000)
• Association of the Endotoxin Antagonist E5564 with High-Density Lipoproteins In Vitro: Dependence on Low-Density and Triglyceride-Rich Lipoprotein Concentrations
  gan: Wasan, Kishor M., et al.
  Cyhoeddwyd: (2003)
• Suppression of Murine Endotoxin Response by E5531, a Novel Synthetic Lipid A Antagonist
  gan: Kobayashi, Seiichi, et al.
  Cyhoeddwyd: (1998)
• Plasma Lipoprotein Distribution of Liposomal Nystatin Is Influenced by Protein Content of High-Density Lipoproteins
  gan: Cassidy, Shawn M., et al.
  Cyhoeddwyd: (1998)
• Safety, Pharmacokinetics, Pharmacodynamics, and Plasma Lipoprotein Distribution of Eritoran (E5564) during Continuous Intravenous Infusion into Healthy Volunteers
  gan: Rossignol, Daniel P., et al.
  Cyhoeddwyd: (2004)